Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy

Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy

Bibliographic Details
Main Authors:	Geeta S. Bhagwat, Rajani B. Athawale, Rajeev P. Gude, Shadab Md, Nabil A. Alhakamy, Usama A. Fahmy, Prashant Kesharwani
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Pharmacology
Subjects:	breast cancer cancer solid lipid nanoparticles tamoxifen targeted drug delivery
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1123542/full

Similar Items

Formulation and Development of Transferrin Targeted Solid Lipid Nanoparticles for Breast Cancer Therapy
by: Geeta S. Bhagwat, et al.
Published: (2020-11-01)

Effects of tamoxifen-loaded erythropoietin-coated nanostructured lipid carrier on breast cancer cells and rat mammary gland tumour
by: Beh, Chaw Yee
Published: (2019)

Recent Progress of RGD Modified Liposomes as Multistage Rocket Against Cancer
by: Afsana Sheikh, et al.
Published: (2022-01-01)

Fabrication, characterization and functionalization of single-walled carbon nanotube conjugated with tamoxifen and its anticancer potential against human breast cancer cells
by: Oskoueian, Arshin
Published: (2018)

Tamoxifen Effects on the lipid profile in premenopausal women with Breast cancer: A follow up study
by: Zainab A. M. Ali, et al.
Published: (2018-12-01)

Biochemical differences between nano- and normal formulation of tamoxifen and other natural bioactive materials ameliorate breast cancer in experimental rats
by: Afaf Ezzat, et al.
Published: (2021-04-01)

Exploring the Relationship Between Tamoxifen and Hereditary Angioedema
by: Ana Raquel Pinto, et al.
Published: (2024-01-01)

Breast Cancer Case using Tamoxifen during Pregnancy: A Case Report and Literature Review
by: Kamal Eldein H. Mohamed, et al.
Published: (2017-07-01)

Uterine Carcinosarcoma Associated with Tamoxifen Use in a Menopausal ‎Patient: A Case Report ‎
by: T Ashrafganjoei, et al.
Published: (2015-12-01)

Formulation, characterization, and cellular toxicity assessment of tamoxifen-loaded silk fibroin nanoparticles in breast cancer
by: Afrasim Moin, et al.
Published: (2021-01-01)

Enhanced Dissolution Efficiency of Tamoxifen Combined with Methacrylate Copolymers in Amorphous Solid Dispersions
by: Dayanne T. C. da Silva, et al.
Published: (2020-11-01)

Clinical factors of the risk of hyperplastic endometry processes on tamoxifen therapy with breast cancer: Retrospective population study
by: Ekaterina O. Golubenko, et al.
Published: (2023-05-01)

Tamoxifen use and risk of endometrial cancer in breast cancer patients: A systematic review and dose–response meta‐analysis
by: Matin Ghanavati, et al.
Published: (2023-04-01)

Mastoparan, a Peptide Toxin from Wasp Venom Conjugated Fluvastatin Nanocomplex for Suppression of Lung Cancer Cell Growth
by: Nabil A. Alhakamy, et al.
Published: (2021-12-01)

QbD Enabled Azacitidine Loaded Liposomal Nanoformulation and Its In Vitro Evaluation
by: Prashant Kesharwani, et al.
Published: (2021-01-01)

Apamin-Conjugated Alendronate Sodium Nanocomplex for Management of Pancreatic Cancer
by: Nabil A. Alhakamy, et al.
Published: (2021-07-01)

Tamoxifen Citrate- loaded synthetic high-density lipoproteins: Assessment of cellular toxicity in breast cancer cells
by: Ameerah A. Radhi, et al.
Published: (2023-02-01)

Polycaprolactone nanofibers as an adjuvant strategy for Tamoxifen release and their cytotoxicity on breast cancer cells
by: Ana D. Pinzón-García, et al.
Published: (2021-10-01)

Tamoxifen Modulates the Immune Landscape of the Tumour Microenvironment: The Paired Siglec-5/14 Checkpoint in Anti-Tumour Immunity in an In Vitro Model of Breast Cancer
by: Przemyslaw Wielgat, et al.
Published: (2023-03-01)

Thymoquinone Could Increase The Efficacy of Tamoxifen Induced Apoptosis in Human Breast Cancer Cells: An In Vitro Study
by: Sedigheh Ganji-Harsini, et al.
Published: (2016-07-01)

DMH1 (4-[6-(4-isopropoxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline) inhibits chemotherapeutic drug-induced autophagy
by: Yue Sheng, et al.
Published: (2015-07-01)

Exosome-Mediated Transfer of Cancer Cell Resistance to Antiestrogen Drugs
by: Svetlana E. Semina, et al.
Published: (2018-04-01)

Endometrial Metastasis from Breast Cancer during Adjuvant Endocrine Therapy
by: Fumikata Hara, et al.
Published: (2010-04-01)

Relationship between Chemotherapy and Tamoxifen with Incidence of Fatty Liver in Women with Breast Cancer
by: Sh Keyhanian, et al.
Published: (2013-08-01)

Spontaneous retrobulbar hemorrhage in a patient with breast cancer: A case report
by: Mohammad Taher Rajabi, et al.
Published: (2016-03-01)

Systematic development and validation of RP-HPLC method for simultaneous estimation of tamoxifen and sulphoraphane with specific application for nanolipidic formulations
by: Bharti Mangla, et al.
Published: (2020-11-01)

Younger tamoxifen-treated breast cancer patients also had higher risk of endometrial cancer and the risk could be reduced by sequenced aromatase inhibitor use: A population-based study in Taiwan
by: Sung-Chao Chu, et al.
Published: (2020-01-01)

Solid Self-Nano Emulsifying Nanoplatform Loaded with Tamoxifen and Resveratrol for Treatment of Breast Cancer
by: Nupur Shrivastava, et al.
Published: (2022-07-01)

Development and In Vitro Evaluation of 2-Methoxyestradiol Loaded Polymeric Micelles for Enhancing Anticancer Activities in Prostate Cancer
by: Nabil A. Alhakamy, et al.
Published: (2021-03-01)

Development, characterization, cytotoxicity and antitumor effect of tamoxifen-loaded solid lipid nanoparticles
by: Abbasalipourkabirreh, Roghayeh
Published: (2010)

Evaluation of Saline Sonohysterography Findings in Patients with Breast Cancer Receiving Tamoxifen Adjuvant Therapy
by: Maryam Rahmani, et al.
Published: (2016-12-01)

Formulation Design, Statistical Optimization, and In Vitro Evaluation of a Naringenin Nanoemulsion to Enhance Apoptotic Activity in A549 Lung Cancer Cells
by: Shadab Md, et al.
Published: (2020-07-01)

Association between tamoxifen and incidence of osteoporosis in Korean patients with ductal carcinoma in situ
by: Dooreh Kim, et al.
Published: (2024-01-01)

Use of Low-Dose Tamoxifen to Increase Mammographic Screening Sensitivity in Premenopausal Women
by: Mikael Eriksson, et al.
Published: (2021-01-01)

Factors Influencing Pharmacokinetics of Tamoxifen in Breast Cancer Patients: A Systematic Review of Population Pharmacokinetic Models
by: Jaya Shree Dilli Batcha, et al.
Published: (2022-12-01)

Tamoxifen and Endometrial Cancer: A Janus-Headed Drug
by: Günter Emons, et al.
Published: (2020-09-01)

Endocrine Risk Factors of Endometrial Cancer: Polycystic Ovary Syndrome, Oral Contraceptives, Infertility, Tamoxifen
by: Atanas Ignatov, et al.
Published: (2020-07-01)

Design and Characterization of Maltoheptaose-<i>b</i>-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen
by: Marcos Antonio Villetti, et al.
Published: (2021-10-01)

The role of tamoxifen in the therapy of metastatic ovarian cancer
by: I S Davidenko, et al.
Published: (2014-03-01)

Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer
by: Liu Y, et al.
Published: (2020-08-01)